Brent L. Wood

1998–2025 年に発表

179
論文数
42,672
被引用数
94
h 指数
175
i10 指数

被引用数

Brent L. Wood の年別被引用数1943 年: 被引用 1 件1997 年: 被引用 2 件1999 年: 被引用 1 件2000 年: 被引用 3 件2001 年: 被引用 9 件2002 年: 被引用 14 件2003 年: 被引用 29 件2004 年: 被引用 31 件2005 年: 被引用 43 件2006 年: 被引用 64 件2007 年: 被引用 70 件2008 年: 被引用 72 件2009 年: 被引用 88 件2010 年: 被引用 129 件2011 年: 被引用 110 件2012 年: 被引用 164 件2013 年: 被引用 236 件2014 年: 被引用 269 件2015 年: 被引用 307 件2016 年: 被引用 322 件2017 年: 被引用 444 件2018 年: 被引用 511 件2019 年: 被引用 1,566 件2020 年: 被引用 1,720 件2021 年: 被引用 1,678 件2022 年: 被引用 1,428 件2023 年: 被引用 1,290 件2024 年: 被引用 2,350 件2025 年: 被引用 1,065 件2026 年: 被引用 18 件1944〜1996 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,137 件、この内訳の 29.9%ドイツ: 引用元論文 1,265 件、この内訳の 7.4%中国: 引用元論文 1,242 件、この内訳の 7.2%イタリア: 引用元論文 983 件、この内訳の 5.7%イギリス: 引用元論文 978 件、この内訳の 5.7%フランス: 引用元論文 762 件、この内訳の 4.4%オランダ: 引用元論文 576 件、この内訳の 3.3%カナダ: 引用元論文 572 件、この内訳の 3.3%スペイン: 引用元論文 566 件、この内訳の 3.3%オーストラリア: 引用元論文 448 件、この内訳の 2.6%日本: 引用元論文 390 件、この内訳の 2.3%スイス: 引用元論文 361 件、この内訳の 2.1%
0%29.9%その他 22.8%

分野

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology15.3%
  • Immunology and Microbiology5%
  • Computer Science0.5%
  • Neuroscience0.2%
  • Nursing0.2%
  • その他0.9%

トピック

  • CAR-T cell therapy research10.7%
  • Acute Myeloid Leukemia Research7.3%
  • Acute Lymphoblastic Leukemia research7.1%
  • Lymphoma Diagnosis and Treatment3.9%
  • Immune Cell Function and Interaction3.4%
  • Chronic Myeloid Leukemia Treatments2.8%
  • その他64.8%

共著者

全論文

検索で開く
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srđan Verstovšek, Wei Wang, Brent L. Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus - Leukemia 2022 被引用: 3,904

  2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph D. Khoury, Hiroshi Kimura, Wolfgang Hiddemann, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao‐Qiu Li, Megan S. Lim, Weiping Liu, Abner Louissaint, Andrea N. Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes‐Moreno, William G. Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok‐Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andy C. Rawstron, Karen L. Rech, Andreas Rosenwald, Jonathan Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A. Sewell, Reiner Siebert, Aliyah R. Sohani, Reuben Tooze, Alexandra Traverse‐Glehen, Francisco Vega, B. Vergier, Ashutosh Wechalekar, Brent L. Wood, Luc Xerri, Wenbin Xiao - Leukemia 2022 被引用: 3,736

  3. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 2,090

  4. CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 被引用: 2,103

  5. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A. van de Loosdrecht, Bert A. van der Reijden, Adriano Venditti, Agnieszka Wierzbowska, Peter J.M. Valk, Brent L. Wood, Roland B. Walter, Christian Thiede, Konstanze Döhner, Gail J. Roboz, Jacqueline Cloos - Blood 2021 被引用: 718

  6. Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells

    著者: , , , , , , , , , , , , , , , - Science Translational Medicine 2016 被引用: 1,010

  7. The genomic landscape of pediatric acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott G. Foy, Dale J. Hedges, Scott Newman, Xin Zhou, Jian Wang, Colleen Reilly, Edgar Sioson, Stephen V. Rice, Victor Pastor Loyola, Gang Wu, Evadnie Rampersaud, Shalini C. Reshmi, Julie M. Gastier-Foster, Jaime M. Guidry Auvil, Patee Gesuwan, Malcolm A. Smith, Naomi Winick, Andrew J. Carroll, Nyla A. Heerema, Richard C. Harvey, Cheryl L. Willman, Eric Larsen, Elizabeth A. Raetz, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Patrick A. Zweidler‐McKay, Karen R. Rabin, Leonard A. Mattano, Kelly W. Maloney, Stuart S. Winter, Michael J. Burke, Wanda L. Salzer, Kimberly P. Dunsmore, Anne Angiolillo, Kristine R. Crews, James R. Downing, Sima Jeha, Ching‐Hon Pui, William E. Evans, Jun J. Yang, Mary V. Relling, Daniela S. Gerhard, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2022 被引用: 397

  8. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberly P. Dunsmore, Stuart S. Winter, Brent L. Wood, Brian P. Sorrentino, James R. Downing, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2017 被引用: 934

  9. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2018 被引用: 1,029

  10. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cheng Cheng, Stefan Roberts, Michael I. Barbato, Dario Campana, Elaine Coustan‐Smith, Sheila Shurtleff, Susana C. Raimondi, Maria Kleppe, Jan Cools, Kristin A. Shimano, Michelle L. Hermiston, Sergei Doulatov, Kolja Eppert, Elisa Laurenti, Faiyaz Notta, John E. Dick, Giuseppe Basso, Stephen P. Hunger, Mignon L. Loh, Meenakshi Devidas, Brent L. Wood, Stuart S. Winter, Kimberly P. Dunsmore, Robert S. Fulton, Lucinda Fulton, Xin Hong, Christopher Harris, David J. Dooling, Kerri Ochoa, Kimberly Johnson, John C. Obenauer, William E. Evans, Ching‐Hon Pui, Clayton W. Naeve, Timothy J. Ley, Elaine R. Mardis, Richard K. Wilson, James R. Downing, Charles G. Mullighan - Nature 2012 被引用: 1,639

  11. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly W. Maloney, Alessandro Rambaldi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Janis Racevskis, Yanming Zhang, Ravi Bhatia, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Williams E. Evans, Sima Jeha, Ching‐Hon Pui, Jun J. Yang, Elisabeth Paietta, James R. Downing, Mary V. Relling, Jinghui Zhang, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Genetics 2019 被引用: 617

  12. Using synthetic templates to design an unbiased multiplex PCR assay

    著者: , , , , , , , , , , , , , - Nature Communications 2013 被引用: 607

  13. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Elliott, Anjali S. Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M. Stone, Selina M. Luger, Charles G. Mullighan, Martin S. Tallman - New England Journal of Medicine 2024 被引用: 215

  14. γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma

    著者: , , , , , , , , , , , , , , , , - Blood 2019 被引用: 324

  15. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , - JAMA Oncology 2017 被引用: 568

  16. γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 98

  17. Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 657

  18. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

    著者: , , , , , , , , , , , , , , , - Blood 2008 被引用: 719

  19. Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Advances 2022 被引用: 140

  20. The genetic basis and cell of origin of mixed phenotype acute leukaemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brent L. Wood, Nyla A. Heerema, Andrew Carrol, Yung‐Li Yang, Malcolm A. Smith, Tanja M. Davidsen, Leandro C. Hermida, Patee Gesuwan, Marco A. Marra, Yussanne Ma, Andrew J. Mungall, Richard A. Moore, Steven J.M. Jones, Marcus B. Valentine, Laura J. Janke, Jeffrey E. Rubnitz, Ching‐Hon Pui, Liang Ding, Yu Liu, Jinghui Zhang, Kim E. Nichols, James R. Downing, Xueyuan Cao, Lei Shi, Stanley Pounds, Scott Newman, Deqing Pei, Jaime M. Guidry Auvil, Daniela S. Gerhard, Stephen P. Hunger, Hiroto Inaba, Charles G. Mullighan - Nature 2018 被引用: 374

  21. Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199

    著者: , , , , , , , , , , , , , , - Cancer Discovery 2014 被引用: 274

  22. Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

    著者: , , , , , , , , , , , , , , - Haematologica 2017 被引用: 283

  23. Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

    著者: , , , , , , , , , , , , , , , - Blood 2017 被引用: 170

  24. Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Wood, Patrick A. Zweidler‐McKay, Catherine M. Bollard, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz - Journal of Clinical Oncology 2022 被引用: 148